2025 Vision for Oral Contraceptive Pills Market

1. Oral Contraceptive Pills Market Analysis, Size, Share, Growth, Trends, and Forecast To 2025 The oral contraceptive pills market is expected to reach USD 24.0 Billion by 2025 from USD 13.8 Billion in 2016 at a CAGR of 6.4%. Oral contraceptive pills are drugs that prevent pregnancy upon its consumption in a stipulated time during the menstrual cycle. The drug component--estrogen and progesterone hormones prevent the ovary from releasing egg for fertilization.Increase in favorable government policies and rise in awareness among consumers regarding unintended pregnancies are set to drive the market over the forecast period. Increasing population and various awareness initiatives that witness a good participation of women, adolescents, and young people, at all stages of planning, implementation, and evaluation helps in curbing the population as well as creates a demand for contraceptives resulting in increased sales. Get PDF with Technological trends at : https://www.xpodenceresearch.com/Request- Sample/106936 Women are increasingly postponing motherhood in order to prioritize their careers and maintain their job safety. Besides, increase in the number of unstable relationships and high costs involved in raising a child are several factors that are increasingly causing women to postpone pregnancy, thereby fueling this industry. In the developing countries, the supply of contraceptives is lesser than the increasing demand of these drugs. Particularly in Africa, diseases like HIV etc. have made usage of drugs that prevent pregnancy essential for women. Thus, net sales of contraceptive products in developing countries are anticipated to increase the market growth over the forecast period. However, concerns regarding the side efects of products can negatively impact the product demand in future. The oral contraceptive pills market has been bifurcated into combination, progestin-only and others on the basis of product types. Combination pills are sub divided into monophasic pills, triphasic pills and others. The combination oral contraceptive pills pills in this segment is projected to register the highest growth rate over the course of the forecast period which can be attributed to easy availability, preference of consumers and higher efciency in preventing pregnancies. Obtain Report Details with technological advancement at : https://www.xpodenceresearch.com/Reports/Oral-Contraceptive-Pills-Market The key players in the global oral contraceptive pills market include Merck & Co., Inc., Reckitt Benckiser, Teva Pharmaceutical Industries Ltd., Bayer AG, Janssen Global Services, LLC, Allergan,plc (Actavis), Mankind Pharma Ltd., Actavis, Inc., Cooper Surgical, Pfzer, Inc., Piramal Enterprises Ltd., and Church & Dwight Co. About Us: Xpodence Research is a U.S. based Market Research Company and ofers the most extensive collection of progressive surveying syndicated and customized research reports of various categories for private and public industries across the globe.

2. Some of the major companies in the global polyamide market are BASF SE, Formosa Group, Honeywell International Inc. Li Peng Enterprise Co., Invista, Du Pont de Nemours and Company, Radici Group, Solvay, Royal DSM N.V., Ascend Performance Materials Inc. We ofer the comprehensive market research solution for all the industries by performing the in-depth study of industry trends, verticals globally. We believe in building an eternal bond with our customers through providing them inclusive research study both customized and syndicated based on their specifc requirements. The organizations in every industry such as Technology, Pharmaceuticals, Consumable Goods,Food & Beverage and others demands a market-based solutions for various signifcant decisions based on productivity and output globally. Our services are tailored specifcally to our clients by proposing them the potential outcome, based on our in-depth analysis and insights for exploring the growth strategies through providing the best possible decision for quality production. Contact Us: 244 , Madison Avenue New York City, NY - 10016 United States Toll Free : +1-844-445-2861 Email : sales@xpodenceresearch.com